Canaan XI L.P. 13D and 13G filings for Day One Biopharmaceuticals, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2022-11-02 4:15 pm Sale | 2022-10-31 | 13D | Day One Biopharmaceuticals, Inc. DAWN | Canaan XI L.P. | 2,548,403 3.500% | -2,200,000 (-46.33%) | Filing |
| 2022-10-19 5:29 pm Sale | 2022-10-17 | 13D | Day One Biopharmaceuticals, Inc. DAWN | Canaan XI L.P. | 4,748,403 6.500% | -2,215,898 (-31.82%) | Filing |
| 2022-09-22 11:06 am Sale | 2022-09-21 | 13D | Day One Biopharmaceuticals, Inc. DAWN | Canaan XI L.P. | 6,964,301 9.500% | -2,338,998 (-25.14%) | Filing |
| 2022-09-19 2:02 pm Sale | 2022-09-13 | 13D | Day One Biopharmaceuticals, Inc. DAWN | Canaan XI L.P. | 9,303,299 12.700% | -360,346 (-3.73%) | Filing |
| 2021-12-22 4:39 pm Sale | 2021-12-21 | 13D | Day One Biopharmaceuticals, Inc. DAWN | Canaan XI L.P. | 9,663,645 15.600% | -1,072,000 (-9.99%) | Filing |
| 2021-06-10 4:13 pm Purchase | 2021-06-01 | 13D | Day One Biopharmaceuticals, Inc. DAWN | Canaan XI L.P. | 10,735,645 17.300% | 10,735,645 (New Position) | Filing |